In dementia care relying only on randomized controlled trials can leave out a large amount of strong research that reflects ...
Riluzole is a glutamate-modulating agent with neuroprotective properties approved for use in amyotrophic lateral sclerosis. The efficacy and safety of riluzole vs placebo as an adjunct to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results